Dr. Agarwal's Health Care Limited carries a market capitalization of 152.53B, placing it among publicly traded companies globally. Its enterprise value stands at 137.30B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 152.53B |
| Enterprise Value | 137.30B |
Dr. Agarwal's Health Care Limited currently has 316.81M shares outstanding.
| Shares Outstanding | 316.81M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Dr. Agarwal's Health Care Limited trades at a trailing price-to-earnings ratio of 124.30. The price-to-sales ratio is 8.14, and the price-to-book ratio stands at 406.09.
| PE Ratio | 124.30 |
| PS Ratio | 8.14 |
| PB Ratio | 406.09 |
| P/TBV Ratio | 13.31 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Dr. Agarwal's Health Care Limited trades at an EV/EBITDA multiple of 61.01 and an EV/FCF ratio of 299.45. The EV/Sales ratio of 8.68 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 61.01 provides insight into valuation relative to core operating earnings.
| EV / Sales | 8.68 |
| EV / EBITDA | 61.01 |
| EV / EBIT | 61.01 |
| EV / FCF | 299.45 |
Dr. Agarwal's Health Care Limited maintains a current ratio of 1.24, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 50.30, indicating elevated leverage, while an interest coverage ratio of 3.31 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 1.24 |
| Quick Ratio | 0.64 |
| Debt / Equity | 50.30 |
| Debt / EBITDA | 4.74 |
| Interest Coverage | 3.31 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 2.72 |
| Return on Invested Capital (ROIC) | 4.99 |
| Return on Capital Employed (ROCE) | 11.77 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 8.63 |
Over the trailing twelve months, Dr. Agarwal's Health Care Limited has paid 633.30M in income taxes, reflecting an effective tax rate of 32.48.
| Income Tax | 633.30M |
| Effective Tax Rate | 32.48 |
Dr. Agarwal's Health Care Limited's stock has gained approximately 13.2635% over the past 52 weeks. The 50-day moving average sits at 460.95, while the 200-day moving average is 473.32.
| Beta (5Y) | N/A |
| 52-Week Price Change | 13.2635% |
| 50-Day Moving Average | 460.95 |
| 200-Day Moving Average | 473.32 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Dr. Agarwal's Health Care Limited generated 15.81B in revenue and converted that into 1.04B in net income, yielding earnings per share of 4.14. EBITDA reached 2.25B, while operating income came in at 2.25B.
| Revenue | 15.81B |
| Gross Profit | 13.28B |
| Operating Income | 2.25B |
| Pretax Income | 1.95B |
| Net Income | 1.04B |
| EBITDA | 2.25B |
| EBIT | 2.25B |
| Earnings Per Share (EPS) | 4.14 |
Dr. Agarwal's Health Care Limited holds 2.95B in cash and equivalents against 10.66B in total debt, resulting in a net debt position of 667.20M. Total book value stands at 316.80M, with working capital of 1.11B providing operational flexibility.
| Cash & Cash Equivalents | 2.95B |
| Total Debt | 10.66B |
| Net Debt | 667.20M |
| Equity (Book Value) | 316.80M |
| Book Value Per Share | 1.00 |
| Working Capital | 1.11B |
Dr. Agarwal's Health Care Limited operates with a gross margin of 52.45, reflecting its pricing power and cost economics. The operating margin of 14.23 and net profit margin of 6.54 provide insight into operational efficiency.
| Gross Margin | 52.45 |
| Operating Margin | 14.23 |
| Pretax Margin | 12.33 |
| Profit Margin | 6.54 |
| EBITDA Margin | 14.23 |
Dr. Agarwal's Health Care Limited posts an Altman Z-Score of 5.12, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.12 |